NL-OMON45524已完成2 期
The effect of INhaled Glycopyrronium bromide on Excessive Sialorrhea and Drooling in Parkinson disease: a dose finding study - Inhaled glycopyrronium on excessive sialorrhea and drooling (INGESD)
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Diagnosed with Parkinson disease
- •Moderate to severe sialorrhea, defined as a minimum of 4 on the Mier scale. Age > 18 years
- •Able to fill the scoring table (or the partner/carer must be able to)
排除标准
- •Hypersensitivity to glycopyrronium or other excipients
- •Use of medication with known anticholinergic effects
研究者
相似试验
尚未招募
不适用
Inhaled glycopyrronium on excessive sialorrhea and droolingSialorrhea, drooling, Parkinson Disease.Speekselvloed, kwijlen, Ziekte van ParkinsonNL-OMON27582Medisch Spectrum Twente, Enschede10
招募中
2 期
Effects of glycopirronium inhalation therapy evaluated by change of physical activity for untreated chronic obstructive pulmonary disease (COPD) patients.Chronic Obstructive Pulmonary Disease (COPD)JPRN-UMIN000014303Department of Respiratory Medicine, Osaka Police Hospital22
已完成
2 期
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double-blind, placebo controlled trial.NL-OMON30532Medisch Spectrum Twente24
尚未招募
不适用
Efficacy of Glycopyrronium added to Budesonide/Formoterol in patients with Asthma-COPD overlap syndromepatients with Asthma-COPD overlap syndromJPRN-UMIN000026651Toyama City Hospital15
进行中（未招募）
2 期
An investigation into how adding an inhaled steroid to COPD treatment may potentially protect against heart disease.Chronic Obstructive Airways Disease [COPD]RespiratoryISRCTN29148209Hull University Teaching Hospitals NHS Trust40